BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.47
-0.18 (-3.19%)
At close: Sep 29, 2025, 4:00 PM EDT
5.46
-0.01 (-0.18%)
After-hours: Sep 29, 2025, 6:16 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.83 million as of September 29, 2025. Its market cap has increased by 40.60% in one year.
Market Cap
9.83M
Enterprise Value
7.16M
1-Year Change
40.60%
Ranking
Category
Stock Price
$5.47
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.83M, a decrease of -76.67%. That is a compound annual growth rate of -25.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 9.83M | 95.55% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 222.46B |
| BHP Group | 140.29B |
| Rio Tinto Group | 111.17B |
| Southern Copper | 95.03B |
| Newmont | 93.33B |
| The Sherwin-Williams Company | 85.01B |
| Agnico Eagle Mines | 82.09B |
| Ecolab | 76.86B |